Actionnariat et activité des initiés pour Gossamer Bio, Inc. (GOSS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $10.96 |
| Capitalisation | $67M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-24 | Christian Waage | A-Award | 2,900,026 | $508K |
| 2026-08-24 | Peterson Caryn | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Smith Robert Paul JR | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Giraudo Bryan | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Giraudo Bryan | A-Award | 25 | $0 |
| 2026-08-24 | Hasnain Faheem | A-Award | 5,800,051 | $1.0M |
| 2026-08-24 | Hasnain Faheem | A-Award | 166 | $0 |
| 2026-06-04 | Quisel John D | A-Award | 115,000 | $20K |
| 2026-06-04 | Drynan Skye | A-Award | 115,000 | $20K |
| 2026-06-04 | Daniel Thomas O | A-Award | 115,000 | $20K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $60000 | $315000 | $105.2M | $135.0M | $486.1M | $183.4M | $112.0M | $32.1M | $46.1M | $37.7M |
| Placements à Court Terme | 0 | 0 | $123.4M | $266.7M | $26.6M | $141.8M | $143.7M | $264.3M | $248.4M | $99.2M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.3M | $12.5M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $60000 | $445000 | $232.0M | $409.3M | $522.3M | $331.8M | $261.9M | $306.5M | $309.9M | $167.6M |
| Immobilisations Corporelles | 0 | 0 | $3.2M | $15.7M | $16.1M | $10.8M | $9.9M | $4.8M | $5.1M | $4.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $60000 | $445000 | $239.4M | $426.6M | $539.4M | $343.7M | $272.4M | $311.9M | $315.3M | $172.2M |
| Dettes Fournisseurs | $40000 | $97000 | $2.2M | $956000 | $7.5M | $3.2M | $1.5M | $5.5M | $2.3M | $6.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $11.6M | $11.6M | 0 | 0 |
| Passifs Courants | $143000 | $1.3M | $20.4M | $36.9M | $38.6M | $39.9M | $49.2M | $51.6M | $45.0M | $63.4M |
| Dette à Long Terme | $40000 | $6.0M | 0 | $28.5M | $172.4M | $179.1M | $207.7M | $197.4M | $197.5M | $198.5M |
| Passifs Totaux | $183000 | $7.3M | $359.5M | $74.1M | $218.7M | $222.2M | $260.4M | $249.1M | $285.8M | $295.0M |
| Réserves | -$123000 | -$6.9M | -$153.9M | -$334.2M | -$577.5M | -$811.5M | -$1.03B | -$1.21B | -$1.27B | -$1.44B |
| Capitaux Propres | -$123000 | -$6.9M | -$120.1M | $352.5M | $320.7M | $121.5M | $12.1M | $62.8M | $29.5M | -$122.8M |
| Dette Totale | $40000 | $6.0M | 0 | $39.5M | $183.7M | $185.2M | $225.7M | $212.5M | $202.9M | $202.9M |
| Dette Nette | -$20000 | $5.7M | -$228.7M | -$362.2M | -$328.9M | -$140.0M | -$29.9M | -$84.0M | -$91.6M | $66.0M |
| Fonds de Roulement | -$83000 | -$821000 | $211.6M | $372.4M | $483.7M | $291.9M | $212.7M | $254.9M | $264.9M | $104.2M |
Santé financière
| Dette / Capitaux propres | -0.42 |
| Ratio de liquidité | 0.53 |
Rentabilité
| Rentabilité des capitaux propres | 108.75% |
| Rentabilité du capital investi | 670.05% |
| Rentabilité des actifs | -162.91% |
| Marge brute | 99.56% |
| Marge opérationnelle | -311.70% |
| Marge nette | -235.00% |
Entreprises liées: CRVS · FDMT · KALV · LXRX · OLMA · PRTA · RAPT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de GOSS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions